Asset

PALOPEGTERIPARATIDE

Ascendis Pharma A/S Ordinary Share

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 216490NDAASCENDIS PHARMA BONE DISEASES AS

Marketed products (3)

  • YORVIPATH
  • YORVIPATH
  • YORVIPATH